{"doi":"info:doi/10.1371/journal.pmed.1000431","title":
  "Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints",
  "eIssn":"1549-1676","state":1,"archiveName":"pmed.1000431.zip",
  "description":
  "\u003cp\u003eAaron Kesselheim and colleagues analyzed unsealed whistleblower complaints                    against pharmaceutical companies filed in US federal fraud cases that contained                    allegations of off-label marketing, and develop a taxonomy of the various                    off-label practices.\u003c/p\u003e",
  "rights":
  "Kesselheim et al. This is an open-access article distributed under\n                the terms of the Creative Commons Attribution License, which permits unrestricted\n                use, distribution, and reproduction in any medium, provided the original author and\n                source are credited.",
  "language":"en","format":"text/xml","pages":"1-9","eLocationId":
  "e1000431","strkImgURI":"","date":"Apr 5, 2011 12:00:00 AM","volume":"8",
  "issue":"4","journal":"PLoS Med","publisherLocation":
  "San Francisco, USA","publisherName":"Public Library of Science","url":
  "http://dx.doi.org/10.1371%2Fjournal.pmed.1000431","collaborativeAuthors":[],
  "types":["http://rdf.plos.org/RDF/articleType/Research%20Article",
    "http://rdf.plos.org/RDF/articleType/research-article"],"categories":[],
  "assets":[{"doi":"info:doi/10.1371/journal.pmed.1000431","extension":
      "XML","contentType":"text/xml","title":
      "Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints",
      "description":
      "\u003cp\u003eAaron Kesselheim and colleagues analyzed unsealed whistleblower complaints                    against pharmaceutical companies filed in US federal fraud cases that contained                    allegations of off-label marketing, and develop a taxonomy of the various                    off-label practices.\u003c/p\u003e",
      "size":142256},{"doi":"info:doi/10.1371/journal.pmed.1000431",
      "extension":"PDF","contentType":"application/pdf","title":
      "Strategies and Practices in Off-Label Marketing of Pharmaceuticals: A Retrospective Analysis of Whistleblower Complaints",
      "description":
      "\u003cp\u003eAaron Kesselheim and colleagues analyzed unsealed whistleblower complaints                    against pharmaceutical companies filed in US federal fraud cases that contained                    allegations of off-label marketing, and develop a taxonomy of the various                    off-label practices.\u003c/p\u003e",
      "size":127903},{"doi":"info:doi/10.1371/journal.pmed.1000431.t001",
      "contextElement":"table-wrap","extension":"TIF","contentType":
      "image/tiff","title":"Table 1","description":
      "\u003ctitle\u003ePharmaceutical fraud cases related to off-label marketing, January\n                        1996–October 2010.\u003c/title\u003e",
      "size":640104},{"doi":"info:doi/10.1371/journal.pmed.1000431.t001",
      "contextElement":"table-wrap","extension":"PNG_S","contentType":
      "image/png","title":"Table 1","description":
      "\u003ctitle\u003ePharmaceutical fraud cases related to off-label marketing, January\n                        1996–October 2010.\u003c/title\u003e",
      "size":7997},{"doi":"info:doi/10.1371/journal.pmed.1000431.t001",
      "contextElement":"table-wrap","extension":"PNG_M","contentType":
      "image/png","title":"Table 1","description":
      "\u003ctitle\u003ePharmaceutical fraud cases related to off-label marketing, January\n                        1996–October 2010.\u003c/title\u003e",
      "size":155848},{"doi":"info:doi/10.1371/journal.pmed.1000431.t001",
      "contextElement":"table-wrap","extension":"PNG_L","contentType":
      "image/png","title":"Table 1","description":
      "\u003ctitle\u003ePharmaceutical fraud cases related to off-label marketing, January\n                        1996–October 2010.\u003c/title\u003e",
      "size":155411},{"doi":"info:doi/10.1371/journal.pmed.1000431.t002",
      "contextElement":"table-wrap","extension":"TIF","contentType":
      "image/tiff","title":"Table 2","description":
      "\u003ctitle\u003eFrequency of off-label marketing strategies and practices reported in\n                            whistleblower complaints.\u003c/title\u003e",
      "size":549518},{"doi":"info:doi/10.1371/journal.pmed.1000431.t002",
      "contextElement":"table-wrap","extension":"PNG_S","contentType":
      "image/png","title":"Table 2","description":
      "\u003ctitle\u003eFrequency of off-label marketing strategies and practices reported in\n                            whistleblower complaints.\u003c/title\u003e",
      "size":5242},{"doi":"info:doi/10.1371/journal.pmed.1000431.t002",
      "contextElement":"table-wrap","extension":"PNG_M","contentType":
      "image/png","title":"Table 2","description":
      "\u003ctitle\u003eFrequency of off-label marketing strategies and practices reported in\n                            whistleblower complaints.\u003c/title\u003e",
      "size":116409},{"doi":"info:doi/10.1371/journal.pmed.1000431.t002",
      "contextElement":"table-wrap","extension":"PNG_L","contentType":
      "image/png","title":"Table 2","description":
      "\u003ctitle\u003eFrequency of off-label marketing strategies and practices reported in\n                            whistleblower complaints.\u003c/title\u003e",
      "size":117046}],"citedArticles":[{"key":"1","year":1962,"displayYear":
      "1962","note":
      "Public Law 87-781 (codified as amended at 21 U.S.C. § 352                        (n))",
      "collaborativeAuthors":["Kefauver-Harris Drug Amendments"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"2","year":2008,"displayYear":"2008",
      "volumeNumber":5,"volume":"5","title":
      "Off-label promotion, on-target sales.","pages":"e210","eLocationID":
      "e210","journal":"PLoS Med","note":
      "doi:10.1371/journal.pmed.0050210","collaborativeAuthors":[],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Article",
      "authors":[{"fullName":"A Fugh-Berman","givenNames":"A","surnames":
          "Fugh-Berman","suffix":""},{"fullName":"D Melnick","givenNames":
          "D","surnames":"Melnick","suffix":""}],"editors":[]},{"key":"3",
      "year":2008,"displayYear":"2008","volumeNumber":299,"volume":"299",
      "title":
      "FDA guidance on off-label promotion and the state of the                        literature from sponsors.",
      "pages":"1949-1951","eLocationID":"1949","journal":"J Amer Med Assn",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "BM Psaty","givenNames":"BM","surnames":"Psaty","suffix":""},{
          "fullName":"W Ray","givenNames":"W","surnames":"Ray","suffix":""}],
      "editors":[]},{"key":"4","year":2006,"displayYear":"2006",
      "volumeNumber":145,"volume":"145","title":
      "Safeguarding patient welfare: who\u0027s in                        charge?",
      "pages":"305-307","eLocationID":"305","journal":"Ann Intern Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "JE Henney","givenNames":"JE","surnames":"Henney","suffix":""}],
      "editors":[]},{"key":"5","year":2008,"displayYear":"2008",
      "volumeNumber":358,"volume":"358","title":
      "Pharmaceutical promotion to physicians and First Amendment                        rights.",
      "pages":"1727-1732","eLocationID":"1727","journal":"New Engl J Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "AS Kesselheim","givenNames":"AS","surnames":"Kesselheim","suffix":
          ""},{"fullName":"J Avorn","givenNames":"J","surnames":"Avorn",
          "suffix":""}],"editors":[]},{"key":"6","year":2008,"displayYear":
      "2008","volumeNumber":149,"volume":"149","title":
      "Whistleblower-initiated enforcement actions against health care                        fraud and abuse in the United States, 1996 to 2005.",
      "pages":"342-349","eLocationID":"342","journal":"Ann Int Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "AS Kesselheim","givenNames":"AS","surnames":"Kesselheim","suffix":
          ""},{"fullName":"DM Studdert","givenNames":"DM","surnames":
          "Studdert","suffix":""}],"editors":[]},{"key":"7","year":2010,
      "displayYear":"2010","month":"December","day":"16","title":
      "Rapidly increasing criminal and civil monetary penalties against                        the pharmaceutical industry: 1991 to 2010.",
      "note":
      "Available: http://www.citizen.org/hrg1924. Accessed 10 February                        2011",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "S Almashat","givenNames":"S","surnames":"Almashat","suffix":""},{
          "fullName":"C Preston","givenNames":"C","surnames":"Preston",
          "suffix":""},{"fullName":"T Waterman","givenNames":"T","surnames":
          "Waterman","suffix":""},{"fullName":"S Wolfe","givenNames":"S",
          "surnames":"Wolfe","suffix":""}],"editors":[]},{"key":"8","year":
      2009,"displayYear":"2009","month":"September","day":"2","title":
      "Pfizer pays $2.3 billion to settle marketing                        case.",
      "note":"NY Times B4","collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "G Harris","givenNames":"G","surnames":"Harris","suffix":""}],
      "editors":[]},{"key":"9","year":2010,"displayYear":"2010","month":
      "April","day":"29","title":
      "Two Johnson \u0026amp; Johnson subsidiaries to pay over $81                        million to resolve allegations of off-label promotion of                        Topamax.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/April/10-civ-500.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"10","year":2010,"displayYear":"2010","month":"April","day":
      "27","title":
      "Pharmaceutical giant AstraZeneca to pay $520 million for                        off-label drug marketing.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/April/10-civ-487.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"11","year":2010,"displayYear":"2010","month":"May","day":"4",
      "title":
      "Novartis vaccines \u0026amp; diagnostics to pay more than $72                        million to resolve False Claims Act allegations concerning                        TOBI.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/May/10-civ-522.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"12","year":2010,"displayYear":"2010","month":"September","day":
      "15","title":
      "Drug maker Forest pleads guilty; to pay more than $313                        million to resolve criminal charges and False Claims Act                        allegations.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/September/10-civ-1028.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"13","year":2010,"displayYear":"2010","month":"September","day":
      "30","title":
      "Novartis Pharmaceuticals Corp. to pay more than $420                        million to resolve off-label promotion and kickback allegations. 30 Sept                        2010.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/September/10-civ-1102.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"14","year":2010,"displayYear":"2010","month":"September","day":
      "1","title":
      "Allergan agrees to plead guilty and pay $600 million to                        resolve allegations of off-label promotion of Botox®.",
      "note":
      "Available: http://www.justice.gov/opa/pr/2010/September/10-civ-988.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":["Department of Justice"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"15","year":2009,"displayYear":"2009","volumeNumber":71,"volume":
      "71","title":
      "Health care fraud investigations bedevil Pharma industry: if                        you\u0027re not under investigation, it\u0027s only because you\u0027ve                        recently settled.",
      "pages":"21-24","eLocationID":"21","journal":"Pink Sheet",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "B Sandburg","givenNames":"B","surnames":"Sandburg","suffix":""}],
      "editors":[]},{"key":"16","year":2008,"displayYear":"2008",
      "volumeNumber":149,"volume":"149","title":
      "The ADVANTAGE seeding trial: a review of internal                        documents.",
      "pages":"251-258","eLocationID":"251","journal":"Ann Intern Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "KP Hill","givenNames":"KP","surnames":"Hill","suffix":""},{
          "fullName":"JS Ross","givenNames":"JS","surnames":"Ross","suffix":
          ""},{"fullName":"DS Egilman","givenNames":"DS","surnames":
          "Egilman","suffix":""},{"fullName":"HM Krumholz","givenNames":
          "HM","surnames":"Krumholz","suffix":""}],"editors":[]},{"key":
      "17","year":2008,"displayYear":"2008","volumeNumber":299,"volume":
      "299","title":
      "Guest authorship and ghostwriting in publications related to                        rofecoxib: a case study of industry documents from rofecoxib                        litigation.",
      "pages":"1800-1812","eLocationID":"1800","journal":"J Amer Med Assn",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "JS Ross","givenNames":"JS","surnames":"Ross","suffix":""},{
          "fullName":"KP Hill","givenNames":"KP","surnames":"Hill","suffix":
          ""},{"fullName":"DS Egilman","givenNames":"DS","surnames":
          "Egilman","suffix":""},{"fullName":"HM Krumholz","givenNames":
          "HM","surnames":"Krumholz","suffix":""}],"editors":[]},{"key":
      "18","year":2009,"displayYear":"2009","volumeNumber":69,"volume":
      "69","title":
      "The promotion of olanzapine in primary care: an examination of                        internal industry documents.",
      "pages":"14-20","eLocationID":"14","journal":"Soc Sci Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "GI Spielmans","givenNames":"GI","surnames":"Spielmans","suffix":
          ""}],"editors":[]},{"key":"19","year":2007,"displayYear":"2007",
      "volumeNumber":4,"volume":"4","title":
      "Characteristics and impact of drug detailing for                        gabapentin.",
      "pages":"e134","eLocationID":"e134","journal":"PLoS Med","note":
      "doi:10.1371/journal.pmed.0040134","collaborativeAuthors":[],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Article",
      "authors":[{"fullName":"MA Steinman","givenNames":"MA","surnames":
          "Steinman","suffix":""},{"fullName":"GM Harper","givenNames":
          "GM","surnames":"Harper","suffix":""},{"fullName":"MM Chren",
          "givenNames":"MM","surnames":"Chren","suffix":""},{"fullName":
          "CS Landefeld","givenNames":"CS","surnames":"Landefeld","suffix":
          ""},{"fullName":"LA Bero","givenNames":"LA","surnames":"Bero",
          "suffix":""}],"editors":[]},{"key":"20","year":2006,"displayYear":
      "2006","volumeNumber":145,"volume":"145","title":
      "Narrative review: the promotion of gabapentin: an analysis of                        internal industry documents.",
      "pages":"284-293","eLocationID":"284","journal":"Ann Intern Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "MA Steinman","givenNames":"MA","surnames":"Steinman","suffix":
          ""},{"fullName":"LA Bero","givenNames":"LA","surnames":"Bero",
          "suffix":""},{"fullName":"MM Chren","givenNames":"MM","surnames":
          "Chren","suffix":""},{"fullName":"CS Landefeld","givenNames":
          "CS","surnames":"Landefeld","suffix":""}],"editors":[]},{"key":
      "21","year":2007,"displayYear":"2007","volumeNumber":4,"volume":"4",
      "title":
      "Following the script: how drug reps make friends and influence                        doctors.",
      "pages":"e150","eLocationID":"e150","journal":"PLoS Med","note":
      "doi:10.1371/journal.pmed.0040150","collaborativeAuthors":[],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Article",
      "authors":[{"fullName":"A Fugh-Berman","givenNames":"A","surnames":
          "Fugh-Berman","suffix":""},{"fullName":"S Ahari","givenNames":
          "S","surnames":"Ahari","suffix":""}],"editors":[]},{"key":"22",
      "year":2005,"displayYear":"2005","month":"May","day":"5","title":
      "Memorandum re: marketing of Vioxx to physicians.","note":
      "Available: http://oversight.house.gov/documents/20050505114932-41272.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "HA Waxman","givenNames":"HA","surnames":"Waxman","suffix":""}],
      "editors":[]},{"key":"23","year":2010,"displayYear":"2010",
      "volumeNumber":362,"volume":"362","title":
      "Experiences of whistle-blowers in major fraud litigation against                        pharmaceutical companies.",
      "pages":"1832-1839","eLocationID":"1832","journal":"New Engl J Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "AS Kesselheim","givenNames":"AS","surnames":"Kesselheim","suffix":
          ""},{"fullName":"DM Studdert","givenNames":"DM","surnames":
          "Studdert","suffix":""},{"fullName":"MM Mello","givenNames":"MM",
          "surnames":"Mello","suffix":""}],"editors":[]},{"key":"24","year":
      2009,"displayYear":"2009","volumeNumber":360,"volume":"360","title":
      "Shifting terrain in the regulation of off-label promotion of                        pharmaceuticals.",
      "pages":"1557-1566","eLocationID":"1557","journal":"New Engl J Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "MM Mello","givenNames":"MM","surnames":"Mello","suffix":""},{
          "fullName":"DM Studdert","givenNames":"DM","surnames":"Studdert",
          "suffix":""},{"fullName":"TA Brennan","givenNames":"TA","surnames":
          "Brennan","suffix":""}],"editors":[]},{"key":"25","year":2011,
      "displayYear":"2011","title":
      "Office of Public Affairs Press Releases.","note":
      "Available: http://www.usdoj.gov/03press/03_1_1.html. Accessed 10                        February 2011",
      "collaborativeAuthors":["United States Department of Justice"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"26","year":2011,"displayYear":"2011","title":
      "Public Access to Court Electronic Records.","note":
      "Available: http://pacer.psc.uscourts.gov/. Accessed 10 February                        2011",
      "collaborativeAuthors":["United States Judiciary"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"27","year":1967,"displayYear":"1967","title":
      "The discovery of grounded theory: strategies for qualitative                        research",
      "publisherLocation":"New York","publisherName":
      "Aldine De Gruyter Press","collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "BG Glaser","givenNames":"BG","surnames":"Glaser","suffix":""},{
          "fullName":"AL Strauss","givenNames":"AL","surnames":"Strauss",
          "suffix":""}],"editors":[]},{"key":"28","year":1992,"displayYear":
      "1992","volumeNumber":29,"volume":"29","title":
      "Qualitative data analysis as a public event: the documentation of                        category development procedures.",
      "pages":"253-266","eLocationID":"253","journal":
      "American Educational Research Journal","collaborativeAuthors":[],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Article",
      "authors":[{"fullName":"MA Constas","givenNames":"MA","surnames":
          "Constas","suffix":""}],"editors":[]},{"key":"29","year":1996,
      "displayYear":"1996 August 13","title":
      "Civil Action 1:96-CV-11651-PBS.","note":
      "Available: http://www.drugepi.org/downloads/downloads/WarnerLambert_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US ex rel. Franklin v. Parke-Davis, Division of Warner-Lambert\n                        Company"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"30","year":2007,"displayYear":"2007 August 13",
      "title":"Civil Action 1:04-CV-11780-DPW.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint8.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US ex rel. Collins, et al. v. Pfizer, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"31","year":2006,"displayYear":
      "2006 February 17","title":"Civil Action 05-CV-0387-SJF-KAM.","note":
      "Available: http://www.drugepi.org/downloads/downloads/OrphanMedical_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Lauterbach v. Orphan Medical Inc., Jazz\n                        Pharmaceuticals Inc., and Dr. Peter Gleason"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"32","year":2008,"displayYear":"2008 January 3",
      "title":"Civil Action 2:04-CV-04401-TON.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Cephalon_Complaint4.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US, et al. ex rel. Boise v. Cephalon, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"33","year":2005,"displayYear":
      "2005 October 24","title":"Civil Action 1:05-CV-12115-DPW.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint7.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US ex rel. Kopchinski v. Pfizer, Inc. and Pharmacia Corp"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"34","year":2005,"displayYear":"2005 July 22",
      "title":"Civil Action 3:05-CV-03004-CRB.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Scios_Complaint2.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Stromv. Scios, Inc. and Johnson \u0026 Johnson,\n                        Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"35","year":2007,"displayYear":"2007 April 5",
      "title":"Civil Action 2:04-CV-02389-KHV-GLR.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Medicis_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Mulqueen, et al. v. Medicis Pharmaceutical\n                        Corp"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"36","year":2010,"displayYear":"2010 January 8",
      "title":"Civil Action 03-10395-NMG.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Forest_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Gobble v. Forest Laboratories Inc., Forest\n                        Pharmaceuticals, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"37","year":2010,"displayYear":"2010 August 26",
      "title":"Civil Action 2:06-CV-01630-LDD.","note":
      "Available: http://www.drugepi.org/downloads/downloads/NovartisCase2_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Copeland v. Novartis Pharmaceuticals Corp"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"38","year":2010,"displayYear":"2010 May 24",
      "title":"Civil Action 2:05-CV-06609-JP.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Wyeth_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Sandler and Paris v. Wyeth Pharmaceuticals, Inc. and\n                        Pfizer Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"39","year":2007,"displayYear":"2007 August 24",
      "title":"Civil Action 2:06-CV-00168-MJP.","note":
      "Available: http://www.drugepi.org/downloads/downloads/CellTherapeutics_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US ex rel. Marchese v. Cell Therapeutics, Inc., et al"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"40","year":2009,"displayYear":"2009 August 21",
      "title":"Civil Action 2:07-CV-04106-JCJ.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint5.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Kruszewski v. Pfizer, Inc"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"41","year":2008,"displayYear":"2008 August 1","title":
      "Civil Action 2:04-CV-03479-BMS.","note":
      "Available: http://www.drugepi.org/downloads/downloads/AstraZeneca_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Wetta v. AstraZeneca Corporation"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"42","year":2004,"displayYear":"2004 July 9",
      "title":"Civil Action 04:CV-4323.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Intermune_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US ex rel. Gallagher v. Intermune, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"43","year":2008,"displayYear":"2008 August 1",
      "title":"Civil Action 1:08-CV-11318-DPW.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint2.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US ex rel. Westlock v. Pfizer, Inc., et al"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"44","year":2007,"displayYear":
      "2007 November 21","title":"Civil Action 2:06-CV-00176-WOB.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US ex rel. Liter v. Pfizer, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"45","year":2007,"displayYear":"2007 June 12",
      "title":"Civil Action 1:07-CV-10304-DPW.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Pfizer_Complaint6.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US ex rel. Farber and Schildhauer v. Pfizer, Inc"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"46","year":2005,"displayYear":"2005 October 7","title":
      "Civil Action 3:05-CV-04055-CRB.","note":
      "http://www.drugepi.org/downloads/downloads/Scios_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["US ex rel. Smith v. Scios, Inc., et al"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"47","year":2007,"displayYear":"2007 June 5",
      "title":"Civil Action 1:07-CV-01288-WSD.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Allergan_Complaint2.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US ex rel. Lang and Rushin v. Allergan, Inc"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"48","year":2003,"displayYear":"2003 October 6","title":
      "Civil Action 03-CV-11892-GAO.","note":
      "Available: http://www.drugepi.org/downloads/downloads/Serono_Complaint1.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":[
        "US, et al. ex rel. Garcia and Driscoll v. Serono, Inc"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"49","year":2010,"displayYear":"2010",
      "volumeNumber":363,"volume":"363","title":
      "Toward more uniform conflict disclosures—the updated ICMJE                        conflict of interest reporting form.",
      "pages":"188-189","eLocationID":"188","journal":"New Engl J Med",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Article","authors":[{"fullName":
          "JM Drazen","givenNames":"JM","surnames":"Drazen","suffix":""},{
          "fullName":"PW de Leeuw","givenNames":"PW","surnames":"de Leeuw",
          "suffix":""},{"fullName":"C Laine","givenNames":"C","surnames":
          "Laine","suffix":""},{"fullName":"C Mulrow","givenNames":"C",
          "surnames":"Mulrow","suffix":""},{"fullName":"CD DeAngelis",
          "givenNames":"CD","surnames":"DeAngelis","suffix":""}],"editors":[]},
    {"key":"50","year":2009,"displayYear":"2009","note":"H.R. 3590 § 6002",
      "collaborativeAuthors":["Physician Payments Sunshine Act"],
      "citationType":"http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],
      "editors":[]},{"key":"51","year":2008,"displayYear":"2008","title":
      "Code on interactions with health care                        professionals.",
      "note":
      "Available: http://www.phrma.org/files/attachments/PhRMA%20Marketing%20Code%202008.pdf.                        Accessed 10 February 2011",
      "collaborativeAuthors":["PhRMA"],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[],"editors":[]},
    {"key":"52","year":2006,"displayYear":"2006 September 12","title":
      "Stanford to ban drug makers\u0027 gifts to doctors, even                        pens.",
      "note":"NY Times C2","collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "A Pollack","givenNames":"A","surnames":"Pollack","suffix":""}],
      "editors":[]},{"key":"53","year":2010,"displayYear":
      "2010 October 15","title":
      "Drugmaker CEOs may be targets for U.S. FDA in off-label cases,                        lawyer says.",
      "note":
      "Bloomberg News. Available: http://www.bloomberg.com/news/2010-10-14/drugmaker-executives-may-become-targets-of-fda-for-off-label-promotions.html.                        Accessed 10 February 2011",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "A Edney","givenNames":"A","surnames":"Edney","suffix":""}],
      "editors":[]},{"key":"54","year":2010,"displayYear":
      "2010 November 9","title":
      "Ex-Glaxo executive is charged in drug fraud.","note":"NY Times B2",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "D Wilson","givenNames":"D","surnames":"Wilson","suffix":""}],
      "editors":[]},{"key":"55","year":2010,"displayYear":"2010 March 17",
      "title":
      "Business must change to earn back the public\u0027s                        trust.",
      "note":
      "Reuters. Available: http://blogs.reuters.com/great-debate/2010/03/17/business-must-change-to-earn-back-the-publics-trust/.                        Accessed 10 February 2011",
      "collaborativeAuthors":[],"citationType":
      "http://purl.org/net/nknouf/ns/bibtex#Misc","authors":[{"fullName":
          "J Kindler","givenNames":"J","surnames":"Kindler","suffix":""}],
      "editors":[]}],"relatedArticles":[],"authors":[{"fullName":
      "Aaron S. Kesselheim","givenNames":"Aaron S.","surnames":
      "Kesselheim","suffix":""},{"fullName":"Michelle M. Mello","givenNames":
      "Michelle M.","surnames":"Mello","suffix":""},{"fullName":
      "David M. Studdert","givenNames":"David M.","surnames":"Studdert",
      "suffix":""}],"editors":[{"fullName":"Joseph S. Ross","givenNames":
      "Joseph S.","surnames":"Ross","suffix":""}],"journals":[{"eIssn":
      "1549-1676"}]}
